Ss. Zhou et al., PHOSPHATASE-MEDIATED ENHANCEMENT OF CARDIAC CAMP-ACTIVATED CL- CONDUCTANCE BY A CL- CHANNEL BLOCKER, ANTHRACENE-9-CARBOXYLATE, Circulation research, 81(2), 1997, pp. 219-228
An aromatic carboxylate, anthracene-9-carboxylic acid (9-AC), is known
as a Cl- channel blocker. However, variable 9-AC effects have hithert
o been reported on the cardiac cAMP-activated Cl- conductance, when ap
plied extracellularly. We have reexamined the 9-AC effect on the Cl- c
onductance activated by isoproterenol or forskolin in guinea pig ventr
icular myocytes under whole-cell patch-clamp conditions. The inward cu
rrent was blocked by 9-AC at greater than or equal to 0.5 mmol/L, but
in contrast, the outward current was enhanced at much lower concentrat
ions (ED50, approximate to 13 mu mol/L). 9-AC applied by the intracell
ular perfusion technique increased both the inward and outward current
s. In the presence of intracellular 9-AC, deactivation of the conducta
nce after washout of isoproterenol or forskolin was largely prevented.
9-AC produced an enhancing effect, even after inhibiting the deactiva
tion process by okadaic acid (OA), whereas it failed to produce additi
onal effects in the presence of orthovanadate. Intracellular applicati
on of 9-AC together with OA virtually abolished the current deactivati
on The 9-AC effects on the Cl- conductance were not dependent on intra
cellular Ca2+ or pH. Putative inhibitors of alkaline (bromotetramisole
) and acid phosphatases (tartrate) were without effect. 9-AC failed to
inhibit the activities of purified protein phosphatase (PP)-1, -2A, a
nd -2C. In the extract of guinea pig ventricle, 9-AC (greater than or
equal to 10 mu mol/L for full action) significantly inhibited a fracti
on of endogenous phosphatase activity that was sensitive to orthovanad
ate but not to OA, bromotetramisole, and tartrate. It is concluded tha
t 9-AC blocks cardiac cAMP-activated (cystic fibrosis transmembrane co
nductance regulator) Cl- conductance from the extracellular side but e
nhances the conductance from the intracellular side by inhibiting an o
rthovanadate-sensitive phosphatase distinct from PP-1, -2A, -2B, or -2
C and alkaline or acid phosphatase.